Why Is It Hard to Get Zepbound or Wegovy and What Can I Do? With Dr. Nikita Shah
Have you ever wondered why getting obesity medications like Wegovy or Zepbound feels so complicated and sometimes almost impossible?
Between insurance hoops, high costs, and confusing rules, even patients who qualify often struggle to actually start treatment.
Joining me today to break all of this down is Dr. Nikita Shah, a board-certified obesity medicine physician and founder of WeightSense in Orlando, Florida. Dr. Shah has built her practice around sensible, personalized, and health-focused weight care, helping patients find strategies that work in the real world. She also serves as a board member for the Medical Society of Central Florida, contributes to the Obesity Pillars Journal editorial board, and actively advocates for better obesity care through the Florida Medical Association.
In this episode, she’s sharing the real reasons it’s so hard to access these medications, the safest ways to start, and what patients can do to finally navigate the system and get the care they need.
Obesity Is Not Your Fault And We Have Tools to Help
Obesity is a real medical condition linked to more than 250 health problems, including some cancers. Many people try to manage it on their own, often making several serious attempts before seeking help. This is not a personal failure because our environment makes weight gain easy and long-term weight loss incredibly difficult.
When lifestyle changes alone are not enough, medical tools like prescription medications or bariatric surgery can make a difference. This is similar to treating high blood pressure or diabetes, which often requires more than lifestyle changes. The focus is not on appearance but on protecting long-term health and reducing serious risks.
Doctors often describe themselves as having a toolbox, not a magic wand. At the first visit, they do not automatically reach for medication. Instead, they start with a comprehensive assessment that looks at lifestyle habits, current medications, lab results, and personal goals. From there, they work with patients to choose the right tools. Sometimes the plan is focused on nutrition and exercise alone. Other times it may include medications or even surgery. Plans can change over time as the journey unfolds.
It’s also smart to think about your insurance plan’s out-of-pocket maximum. Depending on how your plan is structured, combining insurance with a coupon could actually save you more than paying the cash price through a mail-order program.
The Hidden Barriers to Obesity Treatment
Access to effective obesity medications is still one of the biggest challenges in weight care. These treatments work well and have strong safety profiles, yet patients often face barriers that have more to do with cost, insurance coverage, and societal perceptions than with the medicine itself.
The first hurdle is cost. Obesity medications can be expensive, and insurance coverage is inconsistent. Unlike treatments for conditions such as breast cancer, depression, high blood pressure, or diabetes, obesity treatment is not automatically covered by most insurance plans. Even though medical organizations in the United States have recognized obesity as a disease for more than a decade, insurers are not required to cover its treatment. Whether coverage is included often depends on the employer, government program, or individual plan, and many choose to exclude obesity care entirely.
This lack of coverage does not just affect newer injectable medications with higher price tags. Many older or generic weight management medications are also excluded, and some insurance plans will not even pay for office visits focused on obesity. That means patients may have to cover the cost of simply speaking with a doctor about nutrition, exercise, or medical weight management strategies.
Behind these barriers is a deeper societal issue: the lingering stigma around obesity. Too often, excess weight is still seen as a personal failing rather than a medical condition, even by some within the healthcare system. This view is out of step with medical science, which clearly shows that obesity is complex and influenced by many factors beyond willpower.
When insurance plans refuse to cover obesity treatment, they limit patients’ access to the tools that could protect their health and prevent more serious conditions in the future. Like any other chronic disease, obesity often requires a combination of prevention strategies and medical treatment. Expanding coverage and treating obesity as the medical condition it truly is would give more patients the chance to improve their health and maintain it long term.
The Confusing Path to Coverage for Obesity Treatments
Figuring out whether insurance will cover weight-loss medications can feel like a maze. The first step is knowing whether you meet the basic medical criteria for these treatments. Most doctors start with your BMI, or body mass index. It’s not a perfect measurement, but it’s the standard starting point. Usually, a BMI of 27 or higher with a weight-related medical condition, or a BMI over 30, qualifies someone for prescription weight-loss medication. Once that box is checked, we can start looking at treatment options, which might include oral medications, injectables, or medicines used for related health conditions.
Next comes the tricky part: insurance coverage. A lot of patients assume their doctor can instantly tell whether a medication is covered, but that’s rarely the case. Even if two people both have UnitedHealthcare, for example, their plans can be completely different. Coverage depends on the exact policy, whether it’s through an employer or purchased on your own, where you live, and the type of plan, like HMO or PPO.
The best way to know for sure is to call your insurance company or check your online member portal. Ask if your plan covers obesity treatment, whether it requires step therapy, and what your cost will be after deductibles and copays. Sometimes a medication is technically covered but still ends up being pricey out-of-pocket.
Even when coverage exists, the details can get confusing. Take Wegovy, for example. It’s approved for weight loss and for people with high cardiovascular risk. Some insurance plans will cover it if you have that heart risk, but not for obesity alone. Zepbound might be approved if you have sleep apnea but denied otherwise. Patients also sometimes hear that Ozempic is covered, but that drug is only FDA-approved for type 2 diabetes, so using it for obesity without diabetes usually doesn’t qualify.
Because of all these moving parts, many clinics use a practical approach: we send the prescription to the pharmacy and see what happens. That’s often the fastest way to find out if it’s approved and what it will cost. Still, patients should expect a little back-and-forth with their insurance company because navigating weight-loss medication coverage is still one of the trickiest parts of obesity care.
Getting Your Obesity Medication: What Patients Need to Know
The next big step is often prior authorization, especially for newer and higher-priced obesity medications. This is the process where your doctor sends paperwork to your insurance company to explain why the medication is medically necessary for you. Even with a strong case, approval is not guaranteed because every insurance company follows its own rules before deciding whether to cover a prescription.
Navigating this step can feel slow and frustrating. Insurance companies may ask for additional details or have specific criteria that must be met before they approve coverage. Some plans even require proof that you have tried other weight management strategies first.
If your medication does get approved, keep in mind that many insurance companies also require ongoing check-ins to maintain coverage. They might ask for proof of weight loss progress or improvements in weight-related health conditions.
The key to handling prior authorization successfully is staying patient and keeping communication open with your doctor’s office. Many clinics are familiar with this process and can help you track the status, respond to insurance requests, and resubmit paperwork if needed. While it may take some back-and-forth, persistence often pays off in getting the medication covered.
How to Save on Older Weight Loss Medications
Even though the newer injectable medications tend to grab all the attention, older options like Qsymia (phentermine/topiramate) and Contrave (naltrexone/bupropion) are still really effective—and a lot more affordable than most people think.
If you call your local pharmacy, you might get quoted something like $300 a month, which sounds steep. But that’s not the full story. These medications were actually the first to use mail-order pharmacy programs, long before the newer injectables had similar setups. If your doctor sends the prescription to the right pharmacy, they’ll usually call you to set up payment and shipping. Through these programs, the cost can drop to under $100 a month, which makes a big difference.
Another way to save is by using generic options instead of the brand-name combo pills. For example, Qsymia can be prescribed as phentermine and topiramate separately, and Contrave can be split into bupropion and naltrexone. Going this route can bring the price down even more, and some insurance plans will cover the generics even if they don’t cover the brand names.
If you’re using insurance, manufacturer coupons are another helpful tool. They change often, so checking the official websites is the easiest way to get the latest offers. These coupons can sometimes bring the cost close to zero, or at least cut a couple hundred dollars off your monthly bill.
It’s also smart to think about your insurance plan’s out-of-pocket maximum. Depending on how your plan is structured, combining insurance with a coupon could actually save you more than paying the cash price through a mail-order program.
The bottom line? Older medications like Qsymia and Contrave are still solid tools in the weight care toolbox. With the right mix of mail-order options, coupons, or generics, they can be both effective and budget-friendly—without the sticker shock of the newer injectables.
Why Most Compounded Anti-Obesity Medications Aren’t Worth the Risk
As obesity medications become more popular, many patients ask about compounded versions as a way to save money. On the surface, it might seem like a budget-friendly option, but there are important safety concerns that make most obesity medicine specialists cautious about prescribing them.
The biggest issue with compounded medications is that you can’t be completely sure what you’re getting. Right now, there are no FDA-approved generics for semaglutide or tirzepatide, which are the active ingredients in Wegovy and Zepbound. Compounded products aren’t regulated the same way as brand-name medications. That means the ingredients, the dose, and even the consistency can vary. Without long-term safety data, it’s hard for doctors to confidently say these versions are safe.
Even though some patients share positive experiences with compounded medications, others have faced problems ranging from side effects to products that didn’t actually work. Most providers stick to brand-name medications because they’re tested, regulated, and predictable, which helps protect patients’ health.
In the past, some clinics tried helping patients get medications from Canadian pharmacies to cut costs. But shipping can be risky, especially with heat or long transit times that might affect the medication. With the programs available now, like NovoCare for Wegovy and LillyDirect for Zepbound, patients can usually get safer, reliable, and often cheaper access without looking outside the country.
Canada may introduce an approved generic version of semaglutide as early as 2026, which could eventually help lower costs in the United States. But for now, the safest and most cost-effective options are either going through insurance or using official manufacturer cash-pay programs for the brand-name medications.
It’s also worth remembering that effective weight management doesn’t rely only on injectables like Wegovy or Zepbound. Lifestyle changes, generic anti-obesity medications, and sometimes bariatric surgery can all play an important role. Even slowing weight gain or improving metabolic risk factors can make a meaningful difference in health.
While compounded medications might seem like an easy shortcut, prioritizing safety and using well-studied, regulated options gives patients the best chance at long-term success.
Navigating obesity care and medication access isn’t easy, but understanding the process is the first step toward getting the right support. With the right combination of medical guidance, safe treatment options, and persistence, patients can finally access the tools that protect their long-term health.
If this episode helped clarify the path forward, be sure to share it with someone who might be struggling to start their own journey. And don’t forget to follow the show for more conversations that break down the challenges of medical weight care into practical, real-world solutions.
More from The Dr. Francavilla Show:
Subscribe to The Dr. Francavilla Show on